Marco Colleoni Selected Research

Inflammatory Breast Neoplasms

1/2018	Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer.
12/2010	Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancer.
9/2008	Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Colleoni Research Topics

Disease

181	Breast Neoplasms (Breast Cancer) 04/2024 - 09/2002
83	Neoplasms (Cancer) 04/2024 - 12/2003
16	Triple Negative Breast Neoplasms 12/2023 - 09/2008
8	Neutropenia 01/2021 - 04/2016
6	Disease Progression 01/2023 - 03/2004
5	Neoplasm Metastasis (Metastasis) 11/2021 - 09/2002
4	Pathologic Complete Response 04/2024 - 08/2014
4	Infections 01/2021 - 01/2018
4	Hypertension (High Blood Pressure) 01/2018 - 12/2007
4	Ductal Carcinoma 09/2015 - 07/2009
3	Alopecia (Baldness) 01/2023 - 01/2019
3	Febrile Neutropenia 01/2021 - 10/2016
3	Heart Failure 01/2020 - 02/2007
3	Arthralgia (Joint Pain) 01/2018 - 02/2007
3	Inflammatory Breast Neoplasms 01/2018 - 09/2008
3	Hypercholesterolemia 04/2017 - 02/2007
3	Lobular Carcinoma 09/2015 - 10/2009
2	Residual Neoplasm 10/2021 - 03/2011
2	Fatigue 12/2020 - 01/2020
2	Nausea 12/2020 - 07/2018
2	Cardiotoxicity 01/2020 - 12/2010
2	Wounds and Injuries (Trauma) 01/2019 - 01/2018
2	Hot Flashes 11/2016 - 02/2007
2	Lymphatic Metastasis 08/2014 - 10/2010
2	Bone Fractures (Bone Fracture) 04/2008 - 02/2007
2	Venous Thromboembolism 10/2007 - 10/2005
1	Leiomyosarcoma 01/2023

Drug/Important Bio-Agent (IBA)

73	Hormones (Hormone)IBA 05/2023 - 10/2004
36	Tamoxifen FDA LinkGeneric 06/2023 - 03/2006
28	Estrogen ReceptorsIBA 01/2023 - 10/2004
27	Letrozole (Femara)FDA LinkGeneric 01/2023 - 02/2007
20	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 06/2004
19	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 03/2004
18	ErbB Receptors (EGF Receptor)IBA 01/2023 - 09/2008
18	Phenobarbital (Luminal)FDA Link 12/2021 - 04/2012
16	Trastuzumab (Herceptin)FDA Link 04/2024 - 09/2006
15	Aromatase InhibitorsIBA 06/2023 - 12/2007
15	palbociclibIBA 01/2022 - 04/2016
14	human ERBB2 proteinIBA 04/2024 - 06/2010
13	exemestane (Aromasin)FDA Link 01/2023 - 07/2014
11	Estrogens (Estrogen)FDA Link 01/2023 - 06/2004
11	Fluorouracil (Carac)FDA LinkGeneric 08/2015 - 09/2005
10	Methotrexate (Mexate)FDA LinkGeneric 12/2023 - 09/2002
10	Biomarkers (Surrogate Marker)IBA 11/2022 - 12/2009
10	Fulvestrant (Faslodex)FDA Link 01/2022 - 09/2012
9	Capecitabine (Xeloda)FDA Link 01/2023 - 10/2008
9	Cisplatin (Platino)FDA LinkGeneric 08/2015 - 11/2006
7	pertuzumabIBA 04/2024 - 01/2018
7	SteroidsIBA 08/2013 - 10/2004
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 09/2008
6	Vinorelbine (Navelbine)FDA LinkGeneric 01/2023 - 12/2008
6	AnthracyclinesIBA 12/2021 - 05/2008
6	Bevacizumab (Avastin)FDA Link 01/2018 - 10/2008
6	Epirubicin (Ellence)FDA LinkGeneric 08/2015 - 11/2006
5	ribociclibIBA 01/2023 - 01/2018
5	liposomal doxorubicin (Doxil)FDA Link 12/2021 - 12/2010
5	Progesterone FDA LinkGeneric 01/2018 - 09/2008
4	ParaffinIBA 12/2023 - 07/2012
4	Formaldehyde (Formol)FDA Link 12/2023 - 07/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2010
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2019 - 12/2003
3	Carboplatin (JM8)FDA LinkGeneric 04/2024 - 01/2018
3	Cyclin-Dependent Kinase 4IBA 01/2022 - 11/2018
3	taxaneIBA 10/2021 - 01/2008
3	Triptorelin Pamoate (Trelstar)FDA Link 10/2019 - 04/2010
3	Alkylating AgentsIBA 08/2014 - 06/2010
3	1-dodecylpyridoxal (PLD)IBA 04/2013 - 12/2010
2	Docetaxel (Taxotere)FDA Link 04/2024 - 10/2022
2	RNA (Ribonucleic Acid)IBA 12/2023 - 11/2021
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023 - 01/2018
2	Thymidine KinaseIBA 01/2023 - 01/2022
2	Gemcitabine FDA Link 10/2021 - 09/2008
2	Androgen Receptors (Androgen Receptor)IBA 12/2020 - 01/2019
2	Biosimilar PharmaceuticalsIBA 01/2020 - 12/2019
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 03/2016
2	MethyltransferasesIBA 08/2014 - 07/2012
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2012 - 06/2012
2	Hemoglobins (Hemoglobin)IBA 06/2012 - 01/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2010 - 01/2009
2	Leucovorin (Folinic Acid)FDA Link 12/2008 - 09/2002
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2004 - 09/2002
1	Granzymes (Granzyme)IBA 09/2023
1	Immune Checkpoint InhibitorsIBA 09/2023
1	avelumabIBA 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	talazoparibIBA 01/2023
1	Epidermal Growth Factor (EGF)IBA 01/2023
1	sperm releasing substanceIBA 01/2022

Therapy/Procedure

95	Therapeutics 04/2024 - 01/2003
72	Drug Therapy (Chemotherapy) 04/2024 - 09/2002
17	Adjuvant Chemotherapy 12/2021 - 04/2003
15	Neoadjuvant Therapy 11/2022 - 02/2008
6	Radiotherapy 12/2020 - 10/2010
6	Mastectomy (Mammectomy) 01/2018 - 10/2010
3	Catheters 10/2007 - 10/2005
2	Drug Tapering 12/2020 - 10/2016
2	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 10/2011
2	Segmental Mastectomy (Lumpectomy) 10/2016 - 11/2012
1	Immunotherapy 09/2023
1	Time-to-Treatment 01/2023